Cardiovascular and Interventional Radiological Society of Europe
10
2
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
CIRSE Emprint Microwave Ablation Registry
Role: lead
Registry on Percutaneous Electrochemotherapy
Role: lead
CIRSE Registry for SIR-Spheres in France (CIRT-FR)
Role: lead
ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia
Role: lead
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Role: lead
BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe
Role: lead
REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia
Role: lead
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
Role: lead
CIRSE Registry for LifePearl Microspheres
Role: lead
CIRSE Registry for SIR-Spheres Therapy
Role: lead
All 10 trials loaded